产品介绍
猫白血病是猫常见的非创伤性致死疾病,是由猫白血病病毒和猫肉瘤病毒引起的恶性肿瘤性传染病。主要特征是恶性淋巴肿瘤、骨髓性白血病以及变性性胸腺萎缩和非再生性贫血等,其中对猫最严重的是恶性淋巴肿瘤。幼猫易感性高,随年龄增长易感性降低。
|
产品名称
|
类型
|
货号
|
来源
|
建议使用
|
应用
|
|
FLV66
|
rAg
|
|
E.coli
|
包被/标记
|
EIA、LF
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human PRLR Recombinant Antibody, APC|抗人PRLR重组抗体,APC(靶标:人催乳素受体) |
298 |
| Anti-Human PRLR Recombinant Antibody , APC|抗人PRLR重组抗体,APC(靶标:人催乳素受体) |
215 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, APC|抗人TSHR/LGR3重组抗体,APC(靶标:人促甲状腺激素受体) |
431 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, APC|抗人TSHR/LGR3重组抗体,APC(靶标:人促甲状腺激素受体) |
259 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, APC|抗人TSHR/LGR3重组抗体,APC(靶标:人促甲状腺激素受体) |
232 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, APC|抗人TSHR/LGR3重组抗体,APC(靶标:人促甲状腺激素受体) |
261 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, APC|抗人TSHR/LGR3重组抗体,APC(靶标:人促甲状腺激素受体) |
492 |
| Anti-Human CD62E/SELE Recombinant Antibody, APC|抗人CD62E/SELE重组抗体,APC(靶标:人CD62E(E-选择素)) |
396 |
| Anti-Human CD62E/SELE Recombinant Antibody, APC|抗人CD62E/SELE重组抗体,APC(靶标:人CD62E(E-选择素)) |
385 |
| Anti-Human CD62E/SELE Recombinant Antibody, APC|抗人CD62E/SELE重组抗体,APC(靶标:人CD62E(E-选择素)) |
226 |
| Anti-Mouse CD62E/SELE Recombinant Antibody , APC|抗小鼠CD62E/SELE重组抗体,APC(靶标:小鼠CD62E(E-选择素)) |
231 |
| Anti-Human CD36L2 Recombinant Antibody, APC|抗人CD36L2重组抗体,APC(靶标:人CD36样蛋白2) |
345 |
| Anti-Human CD127/IL7R Recombinant Antibody, APC|抗人CD127/IL7R重组抗体,APC(靶标:人IL-7受体) |
136 |
| Anti-Human CD127/IL7R Recombinant Antibody, APC|抗人CD127/IL7R重组抗体,APC(靶标:人IL-7受体) |
281 |
| Anti-Human CD127/IL7R Recombinant Antibody, APC|抗人CD127/IL7R重组抗体,APC(靶标:人IL-7受体) |
491 |
| Anti-Human IFNAR1 Recombinant Antibody , APC|抗人IFNAR1重组抗体,APC(靶标:人I型干扰素受体1) |
343 |
| Anti-Mouse IFNAR1 Recombinant Antibody, APC|抗小鼠IFNAR1重组抗体,APC(靶标:小鼠I型干扰素受体1) |
499 |
| Anti-Human CD49b/ITGA2 Recombinant Antibody , APC|抗人CD49b/ITGA2重组抗体,APC(靶标:人CD49b(整合素α2)) |
184 |
| Anti-Human CD105/ENG Recombinant Antibody , APC|抗人CD105/ENG重组抗体,APC(靶标:人CD105/Endoglin) |
442 |
| Anti-Human CD35/CR1 Recombinant Antibody, APC|抗人CD35/CR1重组抗体,APC(靶标:人补体受体1(CD35)) |
389 |